A5010139385- Diverticular Disease and Complications
- Gastrointestinal disorders and treatments
- Esophageal and GI Pathology
- Colorectal Cancer Screening and Detection
- Eosinophilic Esophagitis
- Esophageal Cancer Research and Treatment
- Microscopic Colitis
- Appendicitis Diagnosis and Management
- Inflammatory Bowel Disease
- Anorectal Disease Treatments and Outcomes
- Gastroesophageal reflux and treatments
- Gastric Cancer Management and Outcomes
- Eosinophilic Disorders and Syndromes
- Colorectal Cancer Surgical Treatments
- Gastrointestinal motility and disorders
- Urinary and Genital Oncology Studies
- Pelvic floor disorders treatments
- HIV Research and Treatment
- HIV/AIDS Research and Interventions
- Digestive system and related health
- Biliary and Gastrointestinal Fistulas
- Clostridium difficile and Clostridium perfringens research
- Helicobacter pylori-related gastroenterology studies
- HIV/AIDS drug development and treatment
- Liver Disease Diagnosis and Treatment
University of North Carolina at Chapel Hill
2016-2025
University of North Carolina Health Care
2025
Indiana University School of Medicine
2011-2019
American Gastroenterological Association
2012
American College of Gastroenterology
2012
American Association for the Study of Liver Diseases
2012
World Water Watch
2011
University Hospital and Clinics
2010
Mayo Clinic in Arizona
2010
Mayo Clinic
2010
Background & AimsGastrointestinal (GI), liver, and pancreatic diseases are a source of substantial morbidity, mortality, cost in the United States. Quantification statistical analyses burden these important for researchers, clinicians, policy makers, public health professionals. We gathered data from national databases to estimate GI liver disease States.MethodsWe collected statistics on care utilization ambulatory inpatient setting along with cancers mortality 2007 through 2012. included...
Fecal microbiota-based therapies include conventional fecal microbiota transplant and US Food Drug Administration-approved therapies, live-jslm spores live-brpk. The American Gastroenterological Association (AGA) developed this guideline to provide recommendations on the use of in adults with recurrent Clostridioides difficile infection; severe fulminant C inflammatory bowel diseases, including pouchitis; irritable syndrome.
Background Constipation, a low fiber diet, sedentary lifestyle and gravidity are commonly assumed to increase the risk of hemorrhoids. However, evidence regarding these factors is limited. We examined association between cited prevalence Methods performed cross sectional study participants who underwent colonoscopy in colorectal adenoma prevention trial had detailed assessment bowel habits, diet activity. The presence hemorrhoids was extracted from subjects' reports. used logistic regression...